Boehringer Ingelheim Animal Health USA Inc.
Boehringer Ingelheim Animal Health USA Inc., a subsidiary of the global pharmaceutical company Boehringer Ingelheim, is headquartered in the United States and operates extensively across North America. Founded in 1885, the company has established itself as a leader in the animal health industry, focusing on innovative solutions for both livestock and companion animals. With a diverse portfolio that includes vaccines, parasiticides, and therapeutics, Boehringer Ingelheim is renowned for its commitment to research and development, which drives the creation of unique products tailored to enhance animal well-being. The company’s dedication to advancing animal health has positioned it among the top players in the market, achieving significant milestones in veterinary medicine and animal care.
DitchCarbon Score
How does Boehringer Ingelheim Animal Health USA Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Boehringer Ingelheim Animal Health USA Inc.'s score of 23 is lower than 69% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Boehringer Ingelheim Animal Health USA Inc.'s reported carbon emissions
Boehringer Ingelheim Animal Health USA Inc. currently does not have specific carbon emissions data available for the most recent year, as indicated by the absence of emissions figures. The company is a current subsidiary of Boehringer Ingelheim, and any potential emissions data may be inherited from its parent organisation. However, there are no documented reduction targets or climate pledges outlined for this subsidiary. As a part of the broader industry context, Boehringer Ingelheim is expected to align with global climate initiatives and may adopt strategies to reduce its carbon footprint in the future. The absence of specific emissions data and reduction commitments suggests that the company is in the early stages of formalising its climate strategy. Overall, while Boehringer Ingelheim Animal Health USA Inc. has not yet disclosed specific emissions figures or reduction targets, it is positioned within a corporate family that may influence its future climate commitments.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Boehringer Ingelheim Animal Health USA Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
